For example, AXL overexpression at the cancer cell surface correlates with decreased expression of the major histocompatibility complex 1 (MHC‐1) and increased expression of the immune checkpoint PD‐L1, leading to decreased CD8+ T‐cell antitumor activity.26, 27. This evidence concerns the gene AXL and cancer.